NCT00617903View on ClinicalTrials.gov

Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

PHASE2CompletedINTERVENTIONAL

Enrollment

83

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Papulopustular Rosacea

Interventions

DRUG

Azelaic acid

15% foam to be applied topically twice daily

DRUG

Vehicle foam

Active-ingredient-free vehicle to be applied topically twice daily

Trial Locations (7)

23507

Norfolk

45040

Mason

66062

Olathe

78759

Austin

80209

Denver

87106

Albuquerque

89052

Henderson

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

LEO Pharma

INDUSTRY

NCT00617903 - Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea | Biotech Hunter | Biotech Hunter